Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Sutton, Andrew J ^a,b   Gay, Nigel J ^b   Edmunds, W John ^b   Hope, Vivian D ^a,b   Gill, O Noel ^b   Hickman, Matthew ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE MARKER; DRUG ABUSE; HEALTH SURVEY; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK BEHAVIOR; HUMAN; INFECTION RISK; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MAXIMUM LIKELIHOOD METHOD; NONHUMAN; POPULATION RESEARCH; PREVALENCE; PUBLIC HEALTH SERVICE; RISK ASSESSMENT; SALIVA ANALYSIS; STATISTICAL MODEL; UNITED KINGDOM; VIRUS TRANSMISSION; VOLUNTEER;

ENGLAND; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; MODELS, BIOLOGICAL; PREVALENCE; RISK FACTORS; SUBSTANCE ABUSE, INTRAVENOUS; WALES;

EID: 33746604758     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-93     Document Type: Article

References (18)

1. de Angelis D, Hickman M, Yang S: Estimating long-term trends in the incidence and prevalence of opiate use/injecting drug use and the number of former users: back-calculation methods and opiate overdose deaths. Am J Epidemiol 2004, 160:994-1004.
2. Agency HP, Scotland HP, National Public Health Service for Wales, Ireland CDSCN, CRDHB, UASSG: Shooting Up; Infections among injecting drug users in the United Kingdom 2004, An update: October 2005 London, Health Protection Agency; 2005.
3. Farrington CP: Modelling forces of infection for measles, mumps and rubella. Stat Med 1990, 9:953-967.
4. Noone A, Durante AJ, Brady AR, Majid F, Swan AV, Parry JV, Hart GJ, Connell JA, Perry KR, Joce RE,.: HIV infection in injecting drug users attending centres in England and Wales, 1990-1991. AIDS 1993, 7:1501-1507.
5. Nicoll A, Gill ON, Peckham CS, Ades AE, Parry J, Mortimer P, Goldberg D, Noone A, Bennett D, Catchpole M: The public health applications of unlinked anonymous seroprevalence monitoring for HIV in the United Kingdom. Int J Epidemiol 2000, 29:1-10.
6. Judd A, Parry J, Hickman M, McDonald T, Jordan L, Lewis K, Contreras M, Dusheiko G, Foster G, Gill N. Kemp K, Main J, Murray-Lyon I, Nelson M: Evaluation of a modified commercial assay in detecting antibody to hepatitis C virus in oral fluids and dried blood spots. J Med Virol 2003, 71:49-55.
7. Farrington CP, Kanann MN, Gay NJ: Estimation of the basic reproduction number for infectious diseases from age-stratified serological data. Applied Statistics 2001, 50:251-292.
8. Ades AE, Nokes DJ: Modeling age- and time-specific incidence from seroprevalence:toxoplasmosis. Am J Epidemiol 1993, 137:1022-1034.
9. Sutton AJ, Gay NJ, Edmunds WJ, Andrews NJ, Hope VD, Gill ON: Modelling the Characteristics of the Male Injecting Drug User Population in England and Wales. International Journal of Drug Policy 2005, 16:176-182.
10. Hope VD, Judd A, Hickman M, Lamagni T, Hunter G, Stimson GV, Jones S, Donovan L, Parry JV, Gill ON: Prevalence of hepatitis C among injection drug users in England and Wales: is harm reduction working? Am J Public Health 2001, 91:38-42.
11. Hickman M, Seaman S, de Angelis D: Estimating the relative incidence of heroin use: application of a method for adjusting observed reports of first visits to specialized drug treatment agencies. Am J Epidemiol 2001, 153:632-641.
12. Ades AE, Medley GF: Estimates of disease incidence in women based on antenatal or neonatal seroprevalence data: HIV in New York City. Stat Med 1994, 13:1881-1894.
13. Kretzschmar M, Wiessing L: Modelling the transmission of hepatitis C in injecting drug users. In Hepatitis C and injecting drug use: impact, costs and policy options Edited by: Jager J, Limburg W, Kretzschmar M, Postma M and Wiessing L. Lisbon, European Monitoring Centre for Drugs and Drug Addiction; 2004:143-159.
14. Rothenberg RB, Potterat JJ, Woodhouse DE, Muth SQ, Darrow WW, Klovdahl AS: Social network dynamics and HIV transmission. AIDS 1998, 12:1529-1536.
15. Immunisation against infectious disease - "The Green Book" Update 2005 Edited by: Salisbury DM and Begg NT. London, HMSO; 1996.
16. Judd A, Hickman M, Jones S, McDonald T, Parry JV, Stimson GV, Hall AJ: Incidence of hepatitis C virus and HIV among new injecting drug users in London: prospective cohort study. BMJ 2005, 330:24-25.
17. Anderson MR, May RM: Infectious Diseases of Humans: Dynamics and Control 1st edition. Oxford Science Publications; 1991.
18. Hennekens CH, Buring JE: Epidemiology in Medicine first edition edition. Lippincott Williams and Wilkins; 1987.